Key result
Three-dimensional volumetric imaging in pharmacologic stress echocardiography shows rates of success and accuracy comparable to conventional two-dimensional imaging, while shortening acquisition time.
Why the study?
Does three-dimensional volumetric imaging improve accuracy and acquisition time compared to two-dimensional imaging in stress echocardiography?
Does three-dimensional volumetric imaging improve accuracy and acquisition time compared to two-dimensional imaging in stress echocardiography?
3D stress echocardiography offers faster acquisition and eliminates apical foreshortening compared to 2D imaging, but is currently limited by lower spatial/temporal resolution and unproven feasibility in exercise stress.
Answers are grounded in this paper and cite their sources.
Supports shorter acquisition in pharmacologic stress echocardiography without loss of accuracy; leaves open exercise protocols and outcome impact.
PURPOSE OF REVIEW: Three-dimensional (3D) volumetric imaging has potential advantages in stress echocardiography, including the ability to provide an unlimited number of planes for analysis and more rapid acquisition than conventional two-dimensional (2D) imaging. This review focuses on the advantages and disadvantages of 3D volumetric imaging and the current and future role of the technique in stress echocardiography. RECENT FINDINGS: Three-dimensional volumetric imaging uniformly shortens the time required for acquisition of stress images. The success of imaging is high with pharmacologic stress but the feasibility is not established with exercise stress. The lower spatial and temporal resolution of 3D imaging and artifacts introduced by suboptimal subvolume integration are limitations of the current 3D technique. The ability to provide more planes for analysis has not been clearly shown to improve the accuracy of stress echocardiography. However, 3D imaging eliminates apical foreshortening, which is common with 2D imaging, and may improve detection of apical wall motion abnormalities. SUMMARY: In general, 3D imaging has shown rates of success and accuracy comparable to those of 2D imaging in pharmacologic stress echocardiography. Further studies are needed in larger and more heterogeneous patient populations. As improvements in 3D technology continue, successful application of the technique to exercise echocardiography is likely. Development of automated image registration, quantitative analysis techniques, and single beat acquisition is needed to fully exploit the potential of 3D imaging in the stress laboratory.
No takes yet. Share an insight, caveat, or question.
Sawada et al. (2009) conducted a review in Stress echocardiography. Three-dimensional (3D) volumetric imaging vs. Conventional two-dimensional (2D) imaging was evaluated. Three-dimensional volumetric imaging in pharmacologic stress echocardiography shows rates of success and accuracy comparable to conventional two-dimensional imaging, while shortening acquisition time.
Synapse has enriched 10 related papers. Consider them for comparative context: